REDUCED LUNG-CANCER MORTALITY WITH LOW-DOSE COMPUTED TOMOGRAPHIC SCREENING The National Lung Screening Trial Research Team N Engl J Med 2011;365:395-409.

Slides:



Advertisements
Similar presentations
Please note, these are the actual video-recorded proceedings from the live CME event and may include the use of trade names and other raw, unedited content.
Advertisements

Helical CT Screening for Lung Cancer at Advanced Radiology Consultants
Richard F. Kucera, M.D., and David West, M.D. Pulmonary and Critical Care Associates, Greensburg, Pennsylvania INTRODUCTION CASE PRESENTATION DISCUSSION.
In the name of GOD In the name of GOD.
Joseph J. Muscato, MD, FACP Medical Director Stewart Cancer Center, Boone Hospital.
The Role of Computed Tomography (CT) Screening for Lung Cancer Recommendations from the American College of Chest Physicians and the American Society of.
Lower Dosage CT-guided Lung Biopsy Protocol Maintains Quality, Minimizes Exposure Jeremy Collins, MD Pegah E, Lewandowski RJ, Yaghmai V, Nemcek jr AA,
THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY (ACCORD)
J Thorac Dis 2013;5(S5) Estimated 10 year survival 88%, regardless of treatment Survival rate 92% if surgical resection in 1 month.
Lung Cancer Screening in 2013 Cheryl Czerlanis, MD Loyola University Medical Center March 02, 2013.
Goldstraw et al. J Thorac Oncol 2007 Why should we want to screen? Survival (years)
CONSENSUS: Cooperative North Scandinavian Enalapril Survival Study Purpose To determine whether the ACE inhibitor enalapril reduces mortality in patients.
ODAC May 3, Subgroup Analyses in Clinical Trials Stephen L George, PhD Department of Biostatistics and Bioinformatics Duke University Medical Center.
Henry C. Ginsberg, MD College of Physicians & Surgeons, Columbia University, New York For The ACCORD Study Group.
The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) The LIPID Study Group N Engl J Med 1998;339:
Is low-dose Aspirin use associated with a reduced risk of colorectal cancer ? a QResearch primary care database analysis Prof Richard Logan, Dr Yana Vinogradova,
Carcinoma Lung.
Clinical Solutions for Lung Cancer Screening (LCS)
The Downside of a Cancer Study Extolling CT Scans Tara Parker-Pope NYT – November 15, 2010
How, Who, What Happens Next? Betty C. Tong, MD, MHS Division of Cardiovascular and Thoracic Surgery Co-Director, Lung Cancer Screening Program Duke University.
 Most frequently diagnosed cancer worldwide › About 1.35 million new cases diagnosed worldwide each year  Leading cause of cancer deaths in the United.
Computed Tomography Contrast-enhanced helical CT of the thorax and abdomen that includes the liver and adrenal glands is the standard radiologic investigation.
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
Early Lung Cancer Screening: An Update of the Current Evidence
Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.
Patient is a man, 60 years, smoker (60 p/y), who has lost one of his friend two week ago because of progressive lung cancer. He is worried about his.
Randomized, double-blind, multicenter, controlled trial.
Finding N.E.M.O. Marvin R. Balaan, MD, FCCP System Division Director, Division of Pulmonary and Critical Care Medicine Allegheny Health Network, Pittsburgh.
EPIB-591 Screening Jean-François Boivin 29 September
LUNG CANCER: MORE PREVALENT THAN YOU THINK Anthony D Weaver MD.
Lung Cancer Screening with Low Dose Computed Tomography Todd Robbins, MD Co-Director, Multidisciplinary Thoracic Oncology Program.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
Early Detection of Lung Cancer & Beyond
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
Lung Cancer Screening: Benefits and limitations to its Implementation
BREAST CANCER Breast cancer  Breast cancer is one of the commonest causes of death in many developed countries in middle-aged women, and is becoming.
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
Reduced Lung Cancer Mortality Risk Among Breast Cancer Patients Treated With Anti- Estrogens Rapiti E et al. SABCS 2009;Abstract 35.
[Insert Organization Name] Making the Case for Lung Cancer Screening.
Journal Club Dr. Eyad Al-Saeed Radiation Oncology 12 January, 2008.
N ENGL J MED 호흡기내과 R1 윤수진 SCREENING FOR OCCULT CANCER IN UNPROVOKED VENOUS THROMBOEMBOLISM.
Date of download: 5/28/2016 From: Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S.
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
Cancer Education Day Lung Cancer Screening Update Kirenza Francis, MD, FRCPC, DABR Windsor Radiological Associates May 13, 2016.
Once-Daily Celecoxib Effective for Preventing Sporadic Colorectal Adenomas Slideset on: Arber N, Rácz I, Spicak J, et al. Chemoprevention of colorectal.
CHEST 2014; 145(4): 호흡기내과 R3 박세정. Cigarette smoking ㅡ the most important risk factor for COPD in the US. low value of FEV 1 : an independent predictor.
Lo Screening del Tumore Polmonare: Siamo Pronti? Mario Silva Section of Radiology, Department of Surgical Sciences University of Parma, IT bioMILD Lung.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
R2 정명화 D R Baldwin, S W Duffy, N J Wald, R Page, D M Hansell,J K Field Thorax ; April 2011,Vol 66.
The Natural History of Benign Thyroid Nodules JAMA. 2015;313(9): doi: /jama Modulator Prof. 전숙 / R1 윤수진.
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
Lung Cancer Screening Update
Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Early Surgery versus Conventional Treatment for Infective Endocarditis
Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime Use Peter W. Kim, Yu-te Wu, Charles Cooper, George Rochester, Thamban.
From: Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations: Methods of the U.S. Preventive Services.
Background & Objectives
Pre-session Number2 (Trial-2 /// 8July2013)
폐암검진, 누구에게 필요한가? 분당서울대병원 내과 윤 호일.
LUNG CANCER SCREENING & SMOKING CESSATION
EVALUATING THE EARLY EFFECTS OF TRU-CUT BIOPSY UNDER CT GUIDANCE IN PATIENTS WITH LUNG TUMOUR AT NATIONAL LUNG HOSPITAL. Dr. Phuong Ngoc Anh National Lung.
Lung Cancer Screening Sandra Starnes, MD Professor of Surgery
Lung Cancer screening. The NELSON trial.
Presentation transcript:

REDUCED LUNG-CANCER MORTALITY WITH LOW-DOSE COMPUTED TOMOGRAPHIC SCREENING The National Lung Screening Trial Research Team N Engl J Med 2011;365: R1 Kim Yu Jin / Prof. Jeong Jae Heon

Introduction 2  Lung cancer : an aggressive and heterogeneous disease.  Current or former smokers : elevated risk for the lung cancer  Lung cancer : the leading cause of death from cancer  Randomized trials of screening with the use of CXR with or without cytologic analysis of sputum specimens  no reduction in lung-cancer mortality  Molecular markers in blood, sputum, and bronchial brushings  currently unsuitable for clinical application

3  Several observational studies  low-dose helical CT of the lung detects more nodules and lung cancers  the National Lung Screening Trial (NLST)  randomized trial, to determine whether screening with low- dose CT, as compared with chest radiography, -> reduce mortality from lung cancer among high-risk persons  significant reduction with low-dose CT screening -> both death from lung cancer and death from any cause

METHOD

Methods-Participants 5  Enrolled 1. between 55 and 74 years of age at the time of randomization 2. cigarette smoking of at least 30 pack years 3. ex-smoker : quit within the previous 15ys Excluded 1. received a diagnosis of lung cancer 2. chest CT within 18 months before enrollment 3. had hemoptysis 4. unexplained wt loss of more than 6.8 kg (15 lb) in the preceding year

6 A total of 53,454 persons were enrolled 26,722 : to screening with low-dose CT 26,732 : to screening with chest radiography.

Methods-Screening 7  Screened once a year for 3 years  Results suggestive of lung cancer : 3 times in low dose CT  low-dose CT :  a nodule at least 4 mm in any diameter  other abnormalities that were suspicious for lung cancer.  chest radiography :  a nodule or mass of any size  other abnormalities suspicious for lung cancer  followed for 3.5 additional years with no screening

Methods-Statiscal analysis 8  Statiscal analysis  The primary analysis comparison of lung cancer mortality between the two screening groups according to the intention-to-screen principle  Secondary analyses compared the rate of death from any cause and the incidence of lung cancer in the two groups.

RESULT

Result- Results of Screening 10

Result- Follow-up of Positive Results 11

Result- Incidence, Characteristics, and Treatment of Lung Cancers 12

Result- Incidence, Characteristics, and Treatment of Lung Cancers 13

Result- Lung-Cancer–Specific Mortality 14 Chest radiography 443/143,368 person-years = 309/100,000 person-years Low dose CT 356/144,103 person-years = 247/100,000 person-years the rate of death from lung cancer : 20% reduction

Result- Overall Mortality 15

Conclusion 16  In the NLST, a 20.0% decrease in mortality from lung cancer was observed in the low-dose CT group as compared with the radiography group.  The rate of positive results was higher with low dose CT screening than with radiographic screening by a factor of more than 3  The decrease in the rate of death from any cause with the use of low-dose CT screening suggests that such screening is not, on the whole, deleterious.